In other autoimmune diseases, such as arthritis and multiple sclerosis, it has been described that PRL increases the expression of antiapoptotic genes, such as Bcl2, and decreases the expression of proapoptotic genes, such as Trp63 and Bax, suggesting that this hormone may favor the progression of the disease [47, 48]. This evidence concerns the gene PRL and arthritic joint disease.